User profiles for SELCAN DEMIR

Selcan Demir

Associate Professor of Pediatric Rheumatology, Eskisehir Osmangazi University
Verified email at ogu.edu.tr
Cited by 1593

[HTML][HTML] Kawasaki-like disease in children with COVID-19

…, HH Aykan, ED Batu, E Atalay, S Demir… - Rheumatology …, 2020 - Springer
Children with Coronavirus disease 2019 (COVID-19) are being reported to have manifestations
of hyperinflammatory states and/or Kawasaki-like disease. In this study, we investigated …

[HTML][HTML] Familial Mediterranean fever: recent developments in pathogenesis and new recommendations for management

S Özen, ED Batu, S Demir - Frontiers in immunology, 2017 - frontiersin.org
Familial Mediterranean fever (FMF) is the most common monogenic autoinflammatory
disease (AID) affecting mainly the ethnic groups originating from Mediterranean basin. The …

Common genetic susceptibility loci link PFAPA syndrome, Behçet's disease, and recurrent aphthous stomatitis

…, S Preite, F Dedeoglu, S Demir… - Proceedings of the …, 2020 - National Acad Sciences
Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome is
the most common periodic fever syndrome in children. The disease appears to cluster in …

Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature

HE Sönmez, S Demir, Y Bilginer, S Özen - Clinical Rheumatology, 2018 - Springer
Our aim was to report our experiences of pediatric macrophage activation syndrome (MAS)
patients treated with anakinra and to review previous studies reporting anakinra treatment in …

[HTML][HTML] Vasculitis in systemic autoinflammatory diseases

S Demir, E Sag, F Dedeoglu, S Ozen - Frontiers in Pediatrics, 2018 - frontiersin.org
Autoinflammatory diseases (AID) are diseases of the innate immune system, characterized
by recurrent episodes of localized or systemic inflammation. Vasculitis may accompany AID. …

The performances of the ACR 1997, SLICC 2012, and EULAR/ACR 2019 classification criteria in pediatric systemic lupus erythematosus

…, AP Kısaarslan, E Sağ, F Demir, S Demir… - The Journal of …, 2021 - jrheum.org
Objective. Systemic lupus erythematosus (SLE) is a chronic autoimmune disease. The
American College of Rheumatology (ACR) 1997, Systemic Lupus International Collaborating …

Comparison of IVIG resistance predictive models in Kawasaki disease

…, HH Aykan, O Serin, E Sag, S Demir… - Pediatric …, 2022 - nature.com
Background We aimed to compare the ten different scores (by Kobayashi, Egami, Harada,
Formosa, Sano, Piram et al., Wu et al., Yang et al., Tan et al., and Kanai et al.) to assess their …

[HTML][HTML] Frequency of juvenile idiopathic arthritis and associated uveitis in pediatric rheumatology clinics in Turkey: A retrospective study, JUPITER

…, FZ Kilic, E Sag, HA Dundar, A Adrovic, S Demir… - Pediatric …, 2021 - Springer
Background Juvenile idiopathic arthritis (JIA), is the most common pediatric rheumatologic
disorder with unknown etiology. Currently, no population-based data are available regarding …

Anti-IL1 treatment in colchicine-resistant paediatric FMF patients: real life data from the HELIOS registry

E Sag, F Akal, E Atalay, UK Akca, S Demir… - …, 2020 - academic.oup.com
Objectives FMF is a prototype of autoinflammatory diseases associated with excess IL1
production. Anti-IL1 treatments are the first-line alternatives in colchicine-resistant/intolerant FMF …

Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus

S Demir, J Li, LS Magder, M Petri - Rheumatology, 2021 - academic.oup.com
Objective We evaluated which aPL combinations increase the risk of future thrombosis in
patients with SLE. Methods This prospective cohort study consisted of SLE patients who had …